Change page: Way forward is not obvious at asthma crossroads
- PMID: 17884869
- PMCID: PMC1989002
- DOI: 10.1136/bmj.39339.481667.3A
Change page: Way forward is not obvious at asthma crossroads
Conflict of interest statement
Competing interests: SFH has received sponsorships for organising a CME programme, participating in conferences, and speaking from Astra Zeneca, GSK, and MSD.
Comment on
-
Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control.BMJ. 2007 Sep 8;335(7618):513. doi: 10.1136/bmj.39273.537778.AD. BMJ. 2007. PMID: 17823193 Free PMC article. Review. No abstract available.
References
-
- Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006;368:744-53. - PubMed
-
- American Lung Association Asthma Clinical Research Centers, Peters SP, Anthonisen N, Castro M, et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007;356:2027-39. - PubMed